‘Misconceived’ Sanofi appeal over injector pen patent gets shot down by Full Court

Intellectual Property 2019-02-25 1:34 pm | Melbourne
The Full Court has denied a request by Sanofi that it review a judge’s refusal to block Alphapharm from listing its Semglee insulin injector pen on the PBS, calling the pharmaceutical giant’s appeal “misconceived”.
For information on rights and reprints, contact subscriptions@lawyerly.com.au